The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?
about
Dichotomy in the Epigenetic Mark Lysine Acetylation is Critical for the Proliferation of Prostate Cancer CellsRole of Chemotherapy and Mechanisms of Resistance to Chemotherapy in Metastatic Castration-Resistant Prostate CancerUnique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsLow temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinomaConsistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouseIL-6 promotes prostate tumorigenesis and progression through autocrine cross-activation of IGF-IR.Natriuretic peptide receptor a as a novel target for prostate cancerCombination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer CellsClinical and biological significance of KISS1 expression in prostate cancer.Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancerNeuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells.Understanding and targeting osteoclastic activity in prostate cancer bone metastases.Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling.Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation.Melatonin Inhibits Androgen Receptor Splice Variant-7 (AR-V7)-Induced Nuclear Factor-Kappa B (NF-κB) Activation and NF-κB Activator-Induced AR-V7 Expression in Prostate Cancer Cells: Potential Implications for the Use of Melatonin in Castration-ResiOx-LDL Upregulates IL-6 Expression by Enhancing NF-κB in an IGF2-Dependent Manner in THP-1 Macrophages.Cyclodextrin mediated delivery of NF-κB and SRF siRNA reduces the invasion potential of prostate cancer cells in vitro.Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone.Lipidosterolic extract of serenoa repens modulates the expression of inflammation related-genes in benign prostatic hyperplasia epithelial and stromal cells.Granulocyte-colony stimulating factor (G-CSF) producing malignant pleural mesothelioma: Report of a caseExpression of Id proteins is regulated by the Bcl-3 proto-oncogene in prostate cancer.Polyubiquitination of transforming growth factor β (TGFβ)-associated kinase 1 mediates nuclear factor-κB activation in response to different inflammatory stimuli.PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cellsTNF-blockade in patients with advanced hormone refractory prostate cancer.Prostate-specific IL-6 transgene autonomously induce prostate neoplasm through amplifying inflammation in the prostate and peri-prostatic adipose tissue.Role of miRNA let-7 and its major targets in prostate cancer.Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.Design and Synthesis of New 1,3,5-Trisubstituted Triazines for the Treatment of Cancer and InflammationZoledronic Acid Elicits Proinflammatory Cytokine Profile in Osteolytic Prostate Cancer Cells
P2860
Q26795738-124A13E1-7FCB-4F23-946D-2D9BC4F69613Q28075965-CCD010E9-C306-48E9-83AE-02D8B9BF0F23Q28391298-6CBF5B95-45FE-427F-B62D-39CEBFDF5EC8Q34049627-CF75D6A6-AABF-48EC-936E-D36BE74EAD92Q34917061-5504F28A-C8C3-48A4-880B-8FBD90A503B9Q35037290-92BA9B5F-28C6-4EEE-AFE0-FC2F2AB1D5BDQ35064001-B85C75AC-AB13-4585-8276-469F2CFC36DBQ35858905-EFF0F3AA-2401-47F2-9615-F857D8C921C0Q35952025-F55247A3-336C-427B-819B-92E78359192BQ35976845-A6697DD9-6524-4BE4-8276-DA6143776F6FQ36233076-D3746ACF-8016-4DE0-BC9A-F0407680DC69Q36759374-0947D64C-2F7A-4A0A-9BC9-BCF78E07D42FQ37246666-A1015330-B374-4C3D-899C-30025A5E5B14Q37309865-4133B9DD-9750-4A32-B692-0C02183A021EQ37418939-B58CEFBA-2EE6-42EF-B975-829D7D5589EAQ37968599-C4AC8B38-2D4B-487A-8B83-19CABFA9BE92Q38332633-3C7CB494-A0E8-4457-B782-B5D5A95A1BB0Q38754474-9F0C2591-018C-404B-A7A0-905CEDED44A8Q38865214-C0775B82-7626-4FBE-B138-7384E34F5BBEQ38871314-F981CCAC-5AF4-4283-BDBA-FD61A8C9D2D7Q38956445-DA1E2734-6763-410F-9914-A9494459808BQ39127025-97AF9718-E799-4451-890F-7853A313203AQ39184930-AADE4175-8DDF-4476-9618-6CBB7EBBD09FQ39349217-0562F2D2-E135-48FD-AD36-9BBA5DE4A5A5Q39446055-52A9484D-88A6-422A-8AE6-07493EFFBB90Q39926569-8EC840FC-536C-4115-AA71-3055ED11419EQ40867339-0780A910-9B40-4322-839A-A30CBEC8A1F3Q41204113-F74038AB-4106-4CF5-BD60-3A881FB214CAQ41890041-0B13D388-DCB4-4E7C-B0B8-428AC3DA1EB1Q42151185-E5A21AB4-5A62-48FA-9D8F-4F46331C0C53Q53277140-469EB0D7-14D6-4FDA-9F19-2585EBB747F7Q58707863-A7B36C15-ADCD-4639-8C26-B93ED9339DB1Q59047122-F84D08C7-62C1-4C9D-AEE0-7522109F8720
P2860
The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The NF-kappaB/IL-6 pathway in ...... r: new therapeutic approaches?
@en
type
label
The NF-kappaB/IL-6 pathway in ...... r: new therapeutic approaches?
@en
prefLabel
The NF-kappaB/IL-6 pathway in ...... r: new therapeutic approaches?
@en
P2093
P2860
P1476
The NF-kappaB/IL-6 pathway in ...... r: new therapeutic approaches?
@en
P2093
Alexandre de la Taille
Bernard Paule
Francis Vacherot
Laurence Kheuang
Pascale Soyeux
P2860
P2888
P304
P356
10.1007/S00345-007-0175-6
P577
2007-05-31T00:00:00Z